Translational Nanomedicine international meeting

27,28,29th August 2014

Faculty of medicine, Angers, France

  • August, Wednesday 27th
  • August, Thursday 28th
  • August, Friday 29th

 

Session 1

 

(14h00-15h45)

Topic introduction

 

14h-14h45

  • Welcome Talks : UA Research Vice President, Hospital Director, Town representative

 

  • Scientific opening : Jean-Pierre Benoit, Frederic Lagarce, Arun Kumar

 

14h45-15h45

  • Plenary lecture : Barriers to overcome to allow nanomedicines to reach the market (Ruth Duncan, Cardiff, UK)

 

       
 

 

Coffee Break and poster session 15h45-16h15

 

       

Session 2

 

( 16h15 - 18h45 )

Futur of nanomedicine ressources and fundings

 

16h15-18h45

  • US National cancer Institute's model for multi-disciplinary research in cancer nanotechnology (Piotr Grodzinski, NIH, NCI alliance for nanotechnology, USA)

 

  • European FP7 and future projects (Heico Frima, European comission, Brussels, Belgium )

 

  • European project FP7, TransINT (Maria José Alonso, Santiago de Compostela, Spain)

 

  • European project FP7, FORMAMP (Patrick Saulnier, U Angers, France)

 

  • NanoFar European doctorate (Frank Boury, U Angers, France)

 

       
 

 

7pm Welcome reception

 

       

 

Session 3

 

( 8h30 - 10h15 )

Clinical and preclinical applications of nanomedicine

 

8h30 - 9h15

  • Development of Targeted Nanoassemblies for the Treatment of Cancer
  • (Steven Libutti, A Einstein College of medicine, USA)

 

 9h15 - 9h35

  • Miltefosine lipid nanocapsules for single dose oral therapy of schistosomiasis mansoni 
  • (Alyaa Ramadan, U Alexandria, Egypt)

 

9h35 - 9h55

  • Peptide Nanofibers for siRNA delivery in specific brain region
  • (Mariarosa Mazza, U Manchester, UK)

 

9h55 - 10h15

  • Comparison of passive, active and magnetic targeting of tumors by theranostic nanoparticles
  • (Nathalie Schleich, UC Louvain, Belgium)

 

       
 

 

Coffee Break and poster session 10h15-10h45

 

       

Session 4

 

( 10h45 - 12h55 )

Green technologies and environmental aspects applied to nanomedicines

 

10h15 - 11h30

  • Green nanotechnology – Implications in nanomedicine for the creation of holistic integrative medicine (HIM)
  • (Kattesh Katti, USA)

 

11h30 - 12h15

  • Supercritical fluid in nanomedicine
  • (Enersto Reverchon, U Salerno, Italy)

 

12h15 - 12h55

  • Acute Toxicity and Influence of Gender, Time, and Route of Administration on the Biodistribution of PEGylated Gold Nanorods in BALB/C Mice
  • (Amira Gamal-Eldeen, National Research Center, Cairo, Egypt)

 

12h45 - 13h05

  • Aromatic and terpenic compounds loaded in lipidic nanocapsules: activity against multi-drug resistant Acinetobacter baumannii assessed in vitro and in a murine model of sepsis
  • (Angélique Montagu, U Angers, France)

 

 

 

       
 

 

13h00-14h00 : Lunch

 

       

Session 5

 

( 14h00 - 16h05 )

New applications of nanomedidine

 

14h00-14h45

  • Nanosized therapeutics as sequestering agents
  • (Jean-Christophe Leroux, ETH, Zurich, Switzerland)

 

14h45 - 15h05

  • Tetraphenylporphyrin and Tetraphenylchlorin Nano-Conjugates for Photochemical Internalization
  • (Mar Masson, U of Iceland, Iceland)

 

15h05 - 15h25

  • Polyplex based on polycarbonate polymer for an efficient delivery of anti-angiogenic siRNA
  • (Antoine Frère, U Liege, Belgium)

 

15h25 - 15h45

  • Co-delivery of siRNA and ferrocifen-based drugs by lipid nanocapsules for melanoma treatment
  • (Pauline Resnier, U Angers, France)

 

15h45 - 16h05

  • Colloid-based Drug Delivery Systems
  • (Maria Soler, U Brasilia, Brazil)

 

       
 

 

Coffee Break and poster session 16h05-16h35

 

       

Session 6

 

( 16h35 - 18h45 )

Regulatory requirements and technology transfer in nanomedicine : panel discussion

 

16h35 - 17h00

  • Regulatory aspects of nanomedicines in the EU: overview of the current status
  • (Sandrine Tinton, federal agency for medicines and health products, Belgium)

 

17h00 - 17h25

  • Can we follow existing guidelines to assess the safety of nanomedicinal products ?
  • (Alan Sanh, ANSM, France)

 

17h25 - 17h50

  • Technology transfer foir innovative medical products:
  • view of Aviesan
  • (Nathalie Manaud, Aviesan, France)

 

17h50 - 18h45

  • Panel discussion with Sandrine Tinton, Alan Sanh,
  • Ruth Duncan, Nathalie Manaud

 

       
 

 

20h30 : GALA DINNER

 

       
           

 

Session 7

 

( 8h30 - 10h15 )

Nanomedicine from bench to bedside

 

8h30 - 9h15

  • From physical to chemical encapsulation: a new paradigm for the design of more efficient nanomedicines
  • (Patrick Couvreur, U Paris XI, France)

 

 9h15 - 9h35

  • Nanomedicine for Improved Efficacy of Tuberculosis Drugs 
  • (Rose Hayeshi, CSIR, South Africa)

 

9h35 - 9h55

  • Transcriptionally Targeted Nanoparticles for Cancer Gene Therapy
  • (Helen McCarthy, U Belfast, UK)

 

9h55 - 10h15

  • Nano-technology: formulation, scale-up and cGMP manufacture for clinical investigation
  • (Stéphanie Greco, Sanofi, Vitry, France)

 

       
 

 

Coffee Break and poster session 10h15-10h45

 

       

Session 8

 

( 10h45 - 12h05 )

Development of nanomedicine, Industrial point of view and experience

 

10h45 - 11h05

  • Patent Strategy in Nanomedicine
  • (Tani Chen, Wolf Greenfield, Boston, USA)

 

11h05 - 11h25

  • Translation of nanomedicine to the clinics in the field of ocular delivery
  • (Hongming Chen, Kala Pharmaceuticals, Boston, USA)

 

11h25 - 11h45

  • Development of Leucine5-Enkephalin nanoparticles (NM0127) as pain therapeutic
  • (Andreas Schatzlein, Nanomerics, London, UK)

 

11h45 - 12h05

  • Nanomedicine development: an innovative challenge
  • (Olivier Meyer, Carlina Technologies, Angers, France)

 

 

 

       
 

 

 

       

Session 9

 

( 12h05 - 13h15 )

Preclinical models in nanomedicine

 

12h05 - 12h35

  • Unleashing the Power of Comparative Oncology Models in Nanomedicine Research
  • (Carolyn Henry, U Missouri, USA)

 

12h35 - 12h55

  • Selective targeting of polymer nanocapsules for cancer cells vs. lymphocytes: a 3D cell culture study
  • (M Alonso-Nocelo, CIMUS, Santiago de compostela, Spain)

 

12h55 - 13h15

  • Distribution of Thiamine-Coated Nanoparticles in the Gut Mucosa
  • (Laura Inchaurraga, U Navarra, Spain)

 

 

       
 

 

13h15 - 13h30 : Best poster Award and final Word (Arun Kumar, U Delaware USA)

 

       
           

Translational Nanomedicine © 2014. All Rights Reserved. All images and content (C) the original authors.

Translational nanomedicine international meeting

organisation : Diapason - web agency : www.3wmc.net